Company Filing History:
Years Active: 2013
Title: Marta Pomares: Innovator in Pharmaceutical Chemistry
Introduction
Marta Pomares is a distinguished inventor based in Sant Cugat del Vallès, Spain. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for synthesizing important compounds. Her work is particularly notable for its impact on treatments for neurological disorders.
Latest Patents
Marta Pomares holds one patent for a novel process for the preparation of (6S)-(-)-5,6,7,8-tetrahydro-6-[propyl-(2-thienyl)ethyl]amino-1-naphthol, commonly known as Rotigotine. This invention outlines a detailed method that includes acetylating (S)-(-)-5-hydroxy-N-n-propyl-2-aminotetraline, reacting the acetate with 2-(2-thienyl)ethanol 2-nitrobenzenesulfonate, hydrolyzing the resulting compound, and purifying Rotigotine through various methods. Rotigotine serves as a dopamine agonist and is indicated for the treatment of Parkinson's disease.
Career Highlights
Marta Pomares is currently employed at Interquim, S.A., where she continues to advance her research and development efforts in pharmaceutical innovations. Her expertise in chemical processes has positioned her as a valuable asset in her field.
Collaborations
Marta collaborates with Francisco Marquillas Olondriz, contributing to the advancement of their shared research goals. Their partnership exemplifies the importance of teamwork in scientific innovation.
Conclusion
Marta Pomares is a prominent figure in pharmaceutical chemistry, recognized for her innovative work on Rotigotine. Her contributions continue to influence the treatment of Parkinson's disease and highlight the significance of research in improving healthcare outcomes.